These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12603976)

  • 21. [The use of the Norcolut preparation in gynecologic; practice].
    Bozhinova S
    Akush Ginekol (Sofiia); 1996; 35(3):50-1. PubMed ID: 9045566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonidine in the treatment of menopausal symptoms.
    Salmi T; Punnonen R
    Int J Gynaecol Obstet; 1979; 16(5):422-6. PubMed ID: 35414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levonorgestrel-releasing intrauterine system as an adjunct to estrogen for the treatment of menopausal symptoms--a review.
    Peled Y; Perri T; Pardo Y; Kaplan B
    Menopause; 2007; 14(3 Pt 1):550-4. PubMed ID: 17224852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D; Posea C; Ceausu I; Rusu M
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonidine for menopausal flushing.
    Finkelstein M
    Can Med Assoc J; 1980 Oct; 123(8):722-3. PubMed ID: 7448678
    [No Abstract]   [Full Text] [Related]  

  • 26. Menopausal flushing--an alternative to oestrogen therapy.
    Buckingham L; Davidson G; Greenwood D; Mather B
    Med J Aust; 1976 Oct; 2(14):546. PubMed ID: 994959
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of conventional and new therapies on climacteric symptoms and sexual dysfunction: a concern.
    Wiwanitkit V
    Climacteric; 2010 Feb; 13(1):99. PubMed ID: 20067431
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
    Bjarnason NH
    Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
    Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tibolone: the way to beat many a postmenopausal ailments.
    Lazovic G; Radivojevic U; Marinkovic J
    Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy in women with past history of endometriosis.
    Soliman NF; Hillard TC
    Climacteric; 2006 Oct; 9(5):325-35. PubMed ID: 17000581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy.
    Chittacharoen A; Domhardt R; Manonai J; Theppisai U; Golbs S
    J Med Assoc Thai; 2004 Jan; 87(1):1-7. PubMed ID: 14971528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal pulmonary embolus in a patient treated with Marvelon.
    Scolding NJ; Gibby OM
    J R Coll Gen Pract; 1988 Dec; 38(317):568. PubMed ID: 2978521
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of tibolone versus 17beta-estradiol on climacteric symptoms in women with surgical menopause: a randomized, cross-over study.
    Somunkiran A; Erel CT; Demirci F; Senturk ML
    Maturitas; 2007 Jan; 56(1):61-8. PubMed ID: 16831525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular effects of Org OD 14--a new steroidal therapy for climacteric symptoms.
    Hardiman P; Nihoyannopoulos P; Kicovic P; Ginsburg J
    Maturitas; 1991 Sep; 13(3):235-42. PubMed ID: 1943831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternatives to estrogen for menopausal symptoms.
    Miller KL
    Clin Obstet Gynecol; 1992 Dec; 35(4):884-93. PubMed ID: 1451371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
    Diaby V; Perreault S; Lachaine J
    Maturitas; 2007 Oct; 58(2):138-49. PubMed ID: 17870259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should women who have had breast cancer take hormone replacement therapy?
    Eden J
    Maturitas; 1995 Sep; 22(2):69-70. PubMed ID: 8538486
    [No Abstract]   [Full Text] [Related]  

  • 39. Drospirenone, a progestin with a unique cardiovascular profile, for safe contraception and treatment of menopausal symptoms.
    Ylikorkala O
    Climacteric; 2005 Oct; 8 Suppl 3():1-3. PubMed ID: 16203649
    [No Abstract]   [Full Text] [Related]  

  • 40. Hormone replacement therapy in climacteric and aging brain. International Menopause Society Expert Workshop, 15-18 March 2003, Pisa, Italy.
    Genazzani AR; Gambacciani M; Simoncini T; Schneider HP
    Climacteric; 2003 Sep; 6(3):188-203. PubMed ID: 14567767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.